Clinical Trial Update: Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating sodium-glucose cotransporter 2 inhibitors for pediatric brain tumors and relapsed/refractory pediatric solid tumors. The trial is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Solid Tumor

Snippet

Sponsor: Washington University School of Medicine | Conditions: Pediatric Brain Tumor, Pediatric Solid Tumor | Phase 1 | Status: RECRUITING